시풀류셀T
|
|
시풀류셀T 속성
안전
시풀류셀T C화학적 특성, 용도, 생산
개요
Sipuleucel-T is the first FDA-approved therapeutic cancer vaccine. It is approved for the treatment of asymptomatic or minimally symptomatic metastatic castration-resistant (hormone-refractory) prostate cancer. Sipuleucel-T is described as a therapy rather than a precisely defined therapeutic agent because it is an autologous vaccine that is generated from each individual patient's own blood cells.Originator
Dendreon (United States)상표명
Provenge시풀류셀T 준비 용품 및 원자재
원자재
준비 용품
시풀류셀T 공급 업체
글로벌( 4)공급 업체
| 공급자 | 전화 | 이메일 | 국가 | 제품 수 | 이점 |
|---|---|---|---|---|---|
| NCE Biomedical Co.,Ltd. | 4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988 |
China | 1494 | 55 | |
| China Nobel Chem Co., Limited | +86(0)21 60484900 |
China | 764 | 50 | |
| SPIRO PHARMA | |
eric_feng1954@126.com | China | 9254 | 55 |
| Pushan Industry (Shaanxi) Co., Ltd. | 029-81310890 13571859809 |
info@pushanshiye.com | China | 10004 | 58 |